Epilepsy Trial, Recruiting NCT05609084 Sponsor: Assistance Publique Hopitaux De Marseille Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT05609084
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 16 years or older
  • People whose seizure-producing area involves the temporal region of the brain that controls language
  • People whose brain's language-dominant side has already been identified through prior testing
  • People who are due to have surgery to remove part of the temporal lobe of the brain (including areas linked to memory and/or language), with a surgery date that fits within the study schedule
  • People who have already completed a specific set of thinking and memory tests, known as the NTB score (confirm with trial site)
  • People who have signed a consent form agreeing to take part, or whose parent or legal guardian has signed on their behalf
  • People whose first language learned from childhood is French
  • People who are comfortable using a computer and have access to an internet connection at home
  • People who are covered by, or entitled to benefits from, a social security system

Who may not be able to join:

  • People who have a speech or communication difficulty that could affect how clearly they can speak or use the study's computer system
  • People who have a hearing impairment that has not been corrected (for example, with hearing aids)
  • People whose overall IQ score is below 70, based on testing done within the year before the planned surgery
  • People who are pregnant, currently breastfeeding, legally detained, or under a legal guardianship or protection order

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Francois CREMIEUX, AP-HM

Phone: 0491385298

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
30 March 2023
Est. completion
30 March 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Effect of rehabilitation on immediate postoperative performances

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov